These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ultrasound-guided transrectal biopsy of the prostate]. Mayayo Dehesa T Arch Esp Urol; 1993 Dec; 46(10):849-53. PubMed ID: 7511365 [No Abstract] [Full Text] [Related]
3. [Prostatic biopsy: technic, value and complications]. Gasman D; Abbou CC Ann Urol (Paris); 1995; 29(5):229-301. PubMed ID: 8638906 [No Abstract] [Full Text] [Related]
4. Some concerns about prostate cancer location, Gleason grade, and postradiation doubling times. Stamey TA Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):967-8; discussion 972. PubMed ID: 7591913 [No Abstract] [Full Text] [Related]
5. The prostate biopsy. Harv Mens Health Watch; 2003 Jul; 7(12):4-7. PubMed ID: 12888462 [No Abstract] [Full Text] [Related]
6. [Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer--a multi-institutional update]. Graefen M Aktuelle Urol; 2004 Sep; 35(5):377-8. PubMed ID: 15384003 [No Abstract] [Full Text] [Related]
7. The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number. Ploussard G; Azancot V; Nicolaiew N; Xylinas E; Salomon L; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A BJU Int; 2010 Nov; 106(9):1293-7. PubMed ID: 20456338 [TBL] [Abstract][Full Text] [Related]
8. Incidental prostatic cancer: repeat TURP or biopsy? Martino P; Palazzo S; Battaglia M; Lucarelli G; Selvaggi FP Urol Int; 2004; 73(3):193-7. PubMed ID: 15539835 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen dynamics and prostate cancer diagnosis. Bartoletti R Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286 [No Abstract] [Full Text] [Related]
12. Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium. Stenman UH Eur Urol; 2007 Oct; 52(4):1074-5. PubMed ID: 17383813 [No Abstract] [Full Text] [Related]
13. Case records of the Massachusetts General Hospital. Case 18-2007. A 54-year-old man with early-stage prostate cancer. Kaufman DS; McDougal WS; Zietman AL; Young RH N Engl J Med; 2007 Jun; 356(24):2515-20. PubMed ID: 17568033 [No Abstract] [Full Text] [Related]
14. Pathological definitions and characteristics of stage T1 prostate cancer. Bhargava V Semin Urol Oncol; 1996 Aug; 14(3):145-8. PubMed ID: 8865476 [TBL] [Abstract][Full Text] [Related]
15. Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. Puppo P Eur Urol; 2007 Sep; 52(3):639-41. PubMed ID: 17451871 [No Abstract] [Full Text] [Related]
16. [Conceptual and technical issues in pathologic diagnosis of prostate cancer]. Jiang ZM; Zhang HZ; Zheng L Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):433-5. PubMed ID: 19781187 [No Abstract] [Full Text] [Related]
17. [Puncture biopsy of the prostate]. Lechevallier E Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925 [TBL] [Abstract][Full Text] [Related]